======= ACSM2A =======
== Gene Information ==
* **Official Symbol**: ACSM2A
* **Official Name**: acyl-CoA synthetase medium chain family member 2A
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=123876|123876]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q08AH3|Q08AH3]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=ACSM2A&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ACSM2A|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/614358|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: This gene encodes a mitochondrial acyl-coenzyme A synthetase that is specific for medium chain fatty acids. These enzymes catalyze fatty acid activation, the first step of fatty acid metabolism, through the transfer of acyl-CoA. These enzymes also participate in the glycine conjugation pathway in the detoxification of xenobiotics such as benzoate and ibuprofen. Expression levels of this gene in the kidney may be correlated with kidney function. This gene and its paralog ACSM2B (Gene ID: 348158), both present on chromosome 16, likely arose from a chromosomal duplication event. [provided by RefSeq, May 2017].
* **UniProt Summary**: Has medium-chain fatty acid:CoA ligase activity with broad substrate specificity (in vitro). Acts on acids from C(4) to C(11) and on the corresponding 3-hydroxy- and 2,3- or 3,4- unsaturated acids (in vitro) (By similarity). {ECO:0000250}.
|AMP-binding|
|medium-chain fatty-acyl-CoA metabolic process|
|fatty-acyl-CoA synthase activity|
|fatty acid ligase activity|
|butyrate-CoA ligase activity|
|acyl-CoA ligase activity|
|acylglycerol homeostasis|
|triglyceride homeostasis|
|fatty-acyl-CoA metabolic process|
|acyl-CoA metabolic process|
|thioester metabolic process|
|fatty acid biosynthetic process|
|purine nucleoside bisphosphate metabolic process|
|nucleoside bisphosphate metabolic process|
|ribonucleoside bisphosphate metabolic process|
|lipid homeostasis|
|fatty acid derivative metabolic process|
|glucose homeostasis|
|monocarboxylic acid biosynthetic process|
|carbohydrate homeostasis|
|coenzyme metabolic process|
|carboxylic acid biosynthetic process|
|organic acid biosynthetic process|
|purine ribonucleotide metabolic process|
|fatty acid metabolic process|
|ribonucleotide metabolic process|
|purine nucleotide metabolic process|
|ribose phosphate metabolic process|
|sulfur compound metabolic process|
|purine-containing compound metabolic process|
|mitochondrial matrix|
|cofactor metabolic process|
|nucleotide metabolic process|
|nucleoside phosphate metabolic process|
|monocarboxylic acid metabolic process|
|nucleobase-containing small molecule metabolic process|
|lipid biosynthetic process|
|small molecule biosynthetic process|
|cellular amide metabolic process|
|organophosphate metabolic process|
|carboxylic acid metabolic process|
|cellular lipid metabolic process|
|oxoacid metabolic process|
|organic acid metabolic process|
|carbohydrate derivative metabolic process|
|chemical homeostasis|
|lipid metabolic process|
|mitochondrion|
|ATP binding|
|homeostatic process|
|small molecule metabolic process|
\\
=== CRISPR Data ===
No hits were found.
^Gene^Correlation^
|[[:human genes:r:rrm1|RRM1]]|0.501|
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 15596
* **Expression level (log2 read counts)**: 2.96
{{:chemogenomics:nalm6 dist.png?nolink |}}